Results 161 to 170 of about 268,751 (268)
Postibrutinib outcomes in patients with mantle cell lymphoma.
Blood, 2016 P. Martin, K. Maddocks, J. Leonard, J. Ruan, A. Goy, N. Wagner-Johnston, S. Rule, R. Advani, D. Iberri, T. Phillips, S. Spurgeon, E. Kozin, Katherine Noto, Zhengming Chen, W. Jurczak, R. Auer, E. Chmielowska, S. Stilgenbauer, J. Bloehdorn, C. Portell, Michael E. Williams, M. Dreyling, P. Barr, S. Chen‐Kiang, M. Diliberto, R. Furman, K. Blum +26 moresemanticscholar +1 more sourceImmunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG) [PDF]
, 2005 Georg Lenz, Martin Dreyling, Eva Hoster, Bernhard Wörmann, Ulrich Dührsen, Bernd Metzner, Hartmut Eimermacher, Andreas Neubauer, Hannes Wandt, Hjalmar B. Steinhauer, Sonja Martin, E. Heidemann, Ali Aldaoud, Reza Parwaresch, Joerg Hasford, Michael Unterhalt, Wolfgang Hiddemann +16 moreopenalex +1 more source15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
British Journal of Haematology, 2016 C. Eskelund, A. Kolstad, M. Jerkeman, R. Räty, A. Laurell, S. Eloranta, K. Smedby, S. Husby, L. Pedersen, N. Andersen, M. Eriksson, E. Kimby, H. Bentzen, O. Kuittinen, G. Lauritzsen, H. Nilsson‐Ehle, E. Ralfkiær, M. Ehinger, C. Sundström, J. Delabie, M. Karjalainen-Lindsberg, C. Workman, Christian Garde, E. Elonen, P. Brown, K. Grønbæk, C. Geisler +26 moresemanticscholar +1 more sourceFundamental prognostic difference of ATM gene mutation and deletion in newly diagnosed mantle cell lymphoma. [PDF]
Mol MedObr A, Malarikova D, Kriegova E, Urbankova H, Zemanova Z, Manakova J, Petrackova A, Vatolikova M, Berkova A, Forsterova K, Furst T, Hruskova A, Flodr P, Hanackova V, Prochazka V, Papajik T, Trneny M, Klener P. +17 moreeuropepmc +1 more sourceRetinoic Acid Inhibits the Proliferative Response Induced by CD40 Activation and Interleukin-4 in Mantle Cell Lymphoma [PDF]
, 2005 Massimo Guidoboni, Paola Zancai, Roberta Cariati, Silvana Rizzo, Jessica Dal Col, Alessandro Pavan, Annunziata Gloghini, Michele Spina, Antonio Cuneo, Fabrizio Pomponi, Antonio Bononi, Claudio Doglioni, Roberta Maestro, Antonino Carbone, Mauro Boiocchi, Riccardo Dolcetti +15 moreopenalex +1 more sourceThe novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphoma. [PDF]
Clin Cancer ResJafari H, Brown-Burke F, Pray B, Sloan S, Helmig-Mason J, Hout I, Leon S, Long M, Chan WK, Hanel W, Corps K, Leshchenko VV, Edwards D, Prakash Shukla R, Reci S, Vaddi K, Scherle P, Collier P, La Ferlita A, Singh S, Distefano R, Lapalombella R, Sehgal L, Faryabi RB, Meydan C, Mason CE, Baiocchi RA, Parekh S, Alinari L. +28 moreeuropepmc +1 more sourceHigh Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine [PDF]
, 2005 Jorge Romaguera, Luis Fayad, Maria Alma Rodriguez, Kristine Broglio, Frederick Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, André Goy, Andreas H. Sarris, Nam H. Dang, Michael Wang, Virginia Beasley, L. Jeffrey Medeiros, Ruth L. Katz, Harish K. Gagneja, Barry I. Samuels, Terry L. Smith, Fernando Cabanillas +19 moreopenalex +1 more sourceTumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma. [PDF]
Cell Rep MedWan H, Ren W, Yang M, Nie M, Wasik AM, Du L, de Campos-Mata L, Sun R, Bai Z, Enninful A, Wang Y, Berglund M, Amini RM, Li X, Yang C, Ye X, Yang ZZ, Ansell SM, Liu D, van der Burg M, Fan R, Wu K, Sander B, Pan-Hammarström Q. +23 moreeuropepmc +1 more source
